What is Sonablate?
Founded in 2004 and headquartered in North Carolina, Sonablate Corp operates at the intersection of advanced physics and patient-centric care. The company specializes in the development of high-intensity focused ultrasound technology, a non-invasive approach designed to revolutionize how physicians deliver targeted treatments. By leveraging sound energy for precision healing, Sonablate provides clinicians with sophisticated tools that enhance surgical outcomes while minimizing patient recovery times. The organization maintains a diverse, multidisciplinary team dedicated to refining these therapeutic systems, ensuring that their technological advancements remain at the forefront of modern medical practice.
How much funding has Sonablate raised?
Sonablate has raised a total of $200M across 1 funding round:
Other Financing Round
$200M
Other Financing Round (2026): $200M with participation from Eleven Ventures
Key Investors in Sonablate
Eleven Ventures
A venture capital firm specializing in early-stage and growth-stage technology investments, focusing on companies that demonstrate significant potential for market disruption.
What's next for Sonablate?
With this major enterprise-level funding, Sonablate is poised to enter a new phase of operational scaling and market penetration. The strategic allocation of these resources will likely focus on the expansion of clinical research initiatives and the enhancement of their existing product portfolio. As the company continues to navigate the complexities of the global healthcare market, this infusion of capital provides the necessary runway to solidify its competitive advantage. Future efforts will likely prioritize the integration of next-generation ultrasound capabilities into standard clinical workflows, further cementing Sonablate's reputation as a leader in non-invasive therapeutic innovation.
See full Sonablate company page